Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4865183
Max Phase: Preclinical
Molecular Formula: C52H65N11O7
Molecular Weight: 956.16
Molecule Type: Unknown
Associated Items:
ID: ALA4865183
Max Phase: Preclinical
Molecular Formula: C52H65N11O7
Molecular Weight: 956.16
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1
Standard InChI: InChI=1S/C52H65N11O7/c53-38-10-6-9-36(28-38)48(66)61-46(29-37-31-57-43-21-20-41(64)30-42(37)43)51(69)62-45(27-33-12-14-35(15-13-33)34-7-2-1-3-8-34)50(68)60-44(11-4-5-22-56-52(54)55)49(67)58-32-47(65)59-39-16-18-40(19-17-39)63-23-25-70-26-24-63/h1-3,7-8,12-21,30-31,36,38,44-46,57,64H,4-6,9-11,22-29,32,53H2,(H,58,67)(H,59,65)(H,60,68)(H,61,66)(H,62,69)(H4,54,55,56)/t36-,38-,44-,45-,46-/m0/s1
Standard InChI Key: OOFWFWGDGUEBJI-LNSINPSDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 956.16 | Molecular Weight (Monoisotopic): 955.5068 | AlogP: 3.54 | #Rotatable Bonds: 21 |
Polar Surface Area: 281.91 | Molecular Species: BASE | HBA: 10 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.47 | CX Basic pKa: 11.71 | CX LogP: 2.82 | CX LogD: -1.47 |
Aromatic Rings: 5 | Heavy Atoms: 70 | QED Weighted: 0.03 | Np Likeness Score: -0.45 |
1. Baggio C, Kulinich A, Dennys CN, Rodrigo R, Meyer K, Ethell I, Pellecchia M.. (2021) NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands., 64 (15.0): [PMID:34293864] [10.1021/acs.jmedchem.1c00608] |
Source(1):